Inspire Medical Systems stock is living up to its name, with inspiring earnings growth, ranging from 36% to 390% over the last four quarters, and sales ramping up strongly too. The maker of ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full ...

Learn more about whether Globus Medical, Inc. or Smith & Nephew plc is a better investment based on AAII's A+ Investor grades ...

Globus Medical, Inc. has a 12 month low of $49.33 and a 12 month high of $94.93. The stock has a fifty day simple moving average of $85.85 and a two-hundred day simple moving average of $77.36.

Globus Medical (NYSE:GMED – Get Free Report) last announced its earnings results on Tuesday, November 5th.The medical device company reported $0.83 earnings per share (EPS) for the quarter ...

On Thursday, BofA Securities analyst Craig Bijou upgraded shares of Globus Medical (NYSE:GMED), a medical device company, from Underperform to Neutral and increased the price target to $97 from $80.

BofA analyst Craig Bijou upgraded Globus Medical (GMED) to Neutral from Underperform with a price target of $97, up from $80, after the company preannounced Q4 revenue that was 3% above the Street ...